Sponsor Pipeline

iLeukon Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07452224 ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1)
Get alerts when iLeukon Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free